Related Experiment Video
Updated: Sep 8, 2025

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Do PRO Measures Function the Same Way for all Individuals With Heart Failure?
Theresa M Coles1, Li Lin1, Kevin Weinfurt1
1Center for Health Measurement, Department of Population Health Sciences, Duke University, Durham, North Carolina.
Abstract:
Women diagnosed with heart failure report worse quality of life than men on patient-reported outcome (PRO) measures. An inherent assumption of PRO measures in heart failure is that women and men interpret questions about quality of life the same way. If this is not the case, the risk then becomes that the PRO scores cannot be used for valid comparison or to combine outcomes by subgroups of the population. Inability to compare subgroups validly is a broad issue and has implications for clinical trials, and it also has specific and important implications for identifying and beginning to address health inequities. We describe this threat to validity (the psychometric term is differential item functioning), why it is so important in heart-failure outcomes, the research that has been conducted thus far in this area, the gaps that remain, and what we can do to avoid this threat to validity. PROs bring unique information to clinical decision making, and the validity of PRO measures is key to interpreting differences in heart failure outcomes.
More Related Videos
08:01Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System
Published on: June 11, 2020
09:10Normothermic Ex Situ Heart Perfusion in Working Mode: Assessment of Cardiac Function and Metabolism
Published on: January 12, 2019
Related Concept Videos
Heart Failure V: Medical Management
Mitral Regurgitation IV: Nursing Management
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care
Mitral Regurgitation III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy